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2ABSTRACT
In 1971, Linus Pauling carried out a meta-analysis of four placebo-controlled trials and
concluded that it was highly unlikely that the decrease in the “integrated morbidity of the
common cold” in vitamin C groups was caused by chance alone (P < 0.00003). Studies
carried out since then have consistently found that vitamin C (?1 g/d) alleviates common
cold symptoms, indicating that the vitamin does indeed have physiologic effects on colds.
However, widespread conviction that the vitamin has no proven effects on the common cold
still remains. Three of the most influential reviews drawing this conclusion are considered in
the present article. Two of them are cited in the current edition of the RDA nutritional
recommendations as evidence that vitamin C is ineffective against colds. In this article, these
three reviews are shown to contain serious inaccuracies and shortcomings, making them
unreliable sources on the topic. The second purpose is to suggest possible conceptual reasons
for the persistent resistance to the notion that vitamin C might have effects on colds.
Although placebo-controlled trials have shown that vitamin C does alleviate common cold
symptoms, important questions still remain.
INTRODUCTION
In the early 1970s, Linus Pauling (1,2) suggested that vitamin C (?1 g/d) may substantially
decrease the incidence and severity of common cold episodes. Pauling did not carry out his
own experimental work on the topic but derived his conclusions from earlier studies. Since
Pauling’s analyses a large number of trials have been carried out to examine whether the
vitamin really does have an effect on colds (3,4). These reports have shown that vitamin C
supplementation has no marked effect on common cold incidence in the general population.
However, the symptoms of the common cold have consistently been alleviated. Table I
shows the results of all placebo-controlled trials in which ?2 g/d of vitamin C was
regularly administered to the subjects. All eight studies found a statistically significant
benefit in at least one of the outcome parameters. The combined P value is extremely small
for the five studies published up to 1975, indicating that in 1975 or earlier an unequivocal
conclusion could have been drawn that vitamin C alleviates the symptoms of the common
cold. Six of the eight studies found that the duration or severity of colds was decreased by
more than 20% in the vitamin group, suggesting that the effect may be of practical
importance. Nevertheless, there has been great quantitative variation in the results, hampering
the evaluation of the clinical significance of vitamin C in treating colds (Table I; ref. 3,4).
Although placebo-controlled trials have consistently found benefit from vitamin C on
common cold symptoms, a widespread belief that the vitamin has no real effects on the
common cold still remains (20-22). In this paper we shall briefly analyze three of the most
influential reviews which have concluded that vitamin C has no proven effects on the
common cold (23-25), in order to expose their major shortcomings. The second purpose of
the present work is to suggest possible conceptual reasons why there has been such
persistent resistance to the notion that vitamin C has effects on common cold symptoms.
3TABLE I.  Vitamin C supplementation and common cold symptoms
Study (Ref.) Subjects,
country
Dose
(g/d)
No. of episodes
 in vitamin C
group
Effect on
duration
or severitya
P
(one-tail)
–2 × ln(P)
Studies up to 1975
Anderson et al. 1972 (5, 6) Adults, Canada 1 + 3 b 561 ?21c 0.008 9.66*
?5
Elliott 1973 (7) Military recruits,
USA
2 37d ?72e 0.016 8.27*
Schwartz et al. 1973 (8) Adults, USA 3 ll f ?30g 0.005 10.60*
Coulehan et al. 1974 (9) School children,
USA
2 16 ?29 0.006h 10.23*
Karlowski et al. 1975 (10, 11) Adults, USA 3 + 3b 76 ?17 0.025 7.38*
Studies after 1975
Pitt & Costrini 1979 (12) Military recruits,
USA
2 600 ?5 i 0.012 8.85
?3
Bancalari et al. 1984 (13) School children,
Chile
2 38 ?24 0.041 6.39
Mink et al. 1988 (14) Adults, USA 2 4f ?50 0.023 7.55
        Weighted mean: ?15
                   Median: ?26
                       Mean: ?31
* Five studies up to 1975: ?2 (10 df) = 46.1 combined P (two-tail) = 0.000002.
All eight studies: ?2 (16 df) = 68.9 combined P (two-tail) = 0.00000002.
NOTES: Studies in which ?2 g/d of vitamin C was regularly administered were selected. The eight
studies in the table were double-blind placebo-controlled studies and five were randomized (5,7,10,12,13). For
short-term studies, supplementation was initiated before the symptoms started and continued after the
symptoms ended. Anderson et al.’s (5) 1972 study was included in the table as the dose during the episodes
was 4 g/d although the regular dose was only 1 g/d. Anderson's 1974 study was excluded since there is bias
in the distribution of subjects in the study groups (15,16). For the studies by Anderson et al. (5) and Pitt and
Costrini (12), the days indoors and severity of symptoms, respectively, were selected as outcomes in the
calculations. For a more comprehensive list of the original data see Table 1 in Ref. 3. The weighted mean
was calculated using the number of episodes in the vitamin C group as the weight. The P values were
recalculated when appropriate data were available. The combined P value was calculated by the Fisher
method (17-19).
aThe outcome is the duration of cold symptoms except when otherwise indicated.
bAt the onset of a cold episode an additional 3 g/d was given for 3–5 d.
cDays confined to house per episode.
dThe number of subjects; the number of episodes is not given in the report.
eDays of morbidity  for sore throats.
fInduced rhinovirus infection.
gTotal illness score at the 4th d after challenge.
hP value for comparing the number of sickness days between the groups.
i Severity of symptoms.
4ANALYSIS OF THE THREE MAJOR REVIEWS
Chalmers’ 1975 Review
In 1975 Thomas Chalmers analyzed the results of seven placebo-controlled vitamin C-common
cold studies which he considered technically acceptable (23). He calculated that the episodes were
0.11 ± 0.24 (SE) days shorter in the vitamin C groups compared to the placebo groups. Even if
real, a 0.11 day decrease in the duration of a cold episode is without any clinical significance.
Moreover, the great variation in the results, as indicated by the standard error, suggests that there
probably was no real effect at all.
Recently, Chalmers’ review was shown to contain serious errors (16). For example, in some cases
the data presented were inconsistent with the originally published results. Neither did Chalmers
consider the amount of vitamin C used in the studies, and he included in the meta-analysis a study in
which only 0.025–0.050 g/d of the vitamin was used. The studies known to Chalmers that had used
?1 g/d of vitamin C were recently reanalyzed and the common cold episodes were calculated to be
0.93 ± 0.22 (SE) days shorter in the vitamin groups (16). An estimate more than eight times
Chalmers’ estimate was thus obtained by employing correct values and considering only studies that
used doses as high as Pauling (1,2) had proposed. The problems of Chalmers’ review have been
discussed in more detail elsewhere (16).
Dykes and Meier’s 1975 Review
In 1975, the Journal of the American Medical Association published a review of vitamin C and the
common cold by Michael Dykes and Paul Meier (24), which contained several shortcomings worthy of
note. For instance, while Dykes and Meier discussed the technical aspects of certain studies, in most
cases they did not present the original results, thereby hampering the reader in drawing his or her own
conclusions about the published results.
The primary results of Anderson et al.’s (5) 1972 study were presented by Dykes and Meier, but
certain important findings were neglected. For example, on biological grounds one would expect the
benefit of supplementation to be greater for subjects with a low dietary vitamin C intake. Indeed, in
Anderson’s study vitamin C (1 g/d regularly, 3 g/d extra during a cold) decreased the total number of
“days confined to house” per person by 48% in subjects with a low intake of fruit juices (< 0.12 L/d).
The decrease was only 22% in those with a higher intake of fruit juices (5). Similar results were
obtained in Anderson et al.’s (26) 1975 study, indicating that the subgroup difference was not just
statistical fluctuation.
Dykes and Meier (24) commented on Coulehan’s 1974 study (9) of schoolchildren: “Because the
data required for an appropriate analysis are not presented, the statistical significance of the differences
reported cannot be considered to have been established.” However, Coulehan et al. (9) explicitly
reported that 32% (61 of 190) of lower grade children administered vitamin C were “never ill on active
surveillance,” while only 16% (30 of 192) of those administered placebo were never ill. It is highly
unlikely that such a difference in favor of vitamin C would be caused purely by chance (P = 0.0002; 2-
tailed Fisher’s exact test). The data for children in the higher grades was also presented: 63% (82/131)
of those administered vitamin C were “never ill on active surveillance,” but only 49% (63/128) of
those administered placebo were never ill (P = 0.041; 2-tailed Fisher’s exact test). Thus, important
elements of Coulehan’s (9) results were explicitly published and can be statistically re-analyzed, in
contrast to Dykes and Meier’s claims. Furthermore, Coulehan et al. (9) found that the duration of colds
was 12% and 29% shorter in children administered 1 and 2 g/d of vitamin C respectively suggesting
dose dependency up to 2 g/d, but these data were not given by Dykes and Meier (24).
Karlowski et al. (10) carried out a vitamin C-common cold study at the National Institutes of Health,
which was published in the same issue of the Journal of the American Medical Association as the
5Dykes and Meier review. Karlowski used placebo capsules containing lactose, which can easily be
distinguished from ascorbic acid by taste. The authors suggested that the apparent benefit due to
vitamin C was caused by the placebo effect, as some of the subjects admitted having tasted their
capsules. This interpretation was uncritically reiterated by Dykes and Meier (24). The “placebo effect”
explanation, however, is simply inconsistent with Karlowski’s data (11). Compared to the placebo
group, 3 g/d of vitamin C decreased the duration of colds by 6–9%, whereas 6 g/d decreased it by
17%, suggesting dose dependency up to 6 g/d (10,11). Dykes and Meier did not reveal the results of
Karlowski’s study in their review, apparently due to their faith in the “placebo effect” explanation.
In the case of Ritzel’s study of schoolchildren in a ski resort, Dykes and Meier did not mention that
there was a 29% decrease in the mean duration of episodes, a 45% decrease in the incidence of colds,
and a 61% decrease in the total number of days of illness per person in the group administered 1 g/d of
vitamin C (1,2,27-29). Dykes and Meier (24) merely commented that the difference in cold incidence in
the two groups was only marginally significant (P = 0.04; 2-tailed), which appears to be intentional
camouflaging of the actual results.
Dykes and Meier also discussed a few more studies of lesser importance, but excluded some studies
using large vitamin C doses (?1 g/d), although these had been published prior to their review (29,30).
Truswell's 1986 Minireview
In 1986, the New England Journal of Medicine published a brief analysis of the vitamin C-common
cold studies as a letter by A. Steward Truswell (25). The main text was half a column long, and in this
respect it was a highly superficial review. However, the forum, a journal with great prestige and a very
wide circulation, makes the statements in this minireview influential and worthy of brief comments.
Truswell did not present any figures or P values from the original reports, offering only subjective
conclusions about the studies. He made no efforts to rationalize the great variations in the published
results. For example, on pharmacologic grounds it would seem obvious that the dose is an important
variable affecting the results, yet Truswell made no distinction between studies using 6 g/d (10) and
0.05 g/d (31) of vitamin C.
Truswell (25), referring to certain common cold studies, stated that, “there was no reduction in
duration or severity with ascorbic acid as compared with placebo” (15,31-37). Actually, Coulehan et al.
(32), Clegg and Macdonald (33), and Elwood et al. (34) found a 5–6% shorter duration of cold episodes
in the vitamin C group (1 g/d). Miller et al. (35) found an 8% decrease in the “average duration of
episodes” and a 12% decrease in “days in bed” among twins administered 0.5–1.0 g/d of the vitamin. A
small but reproducible benefit suggests that there may be a real physiologic effect. The effect could be
greater in some other groups of subjects and with larger doses, so that it is inaccurate to describe
these four independent studies as if no reduction were observed at all. Cowan et al. (36) reported 31%
less days lost from school per person in subjects given 0.1–0.2 g/d of vitamin C (1,2). Glazebrook and
Thomson (37) found no effect on the duration of colds, but a 40% decrease in the average stay in the
hospital due to tonsillitis in children administered 0.05–0.3 g/d of vitamin C (1).
At the end of his minireview, Truswell (25) further claims that “in another five combined trials
there appeared to be slight amelioration of symptoms, which was not statistically significant”
(10,12,38-40). In fact, all of the six studies reported in the five papers cited had found a statistically
significant benefit in one of the outcome parameters (Table II). Thus, Truswell’s statement is
gravely misleading, even though the five reports did contain some other outcomes in which the
benefit was not significant statistically.
6TABLE II. Five trials in which the amelioration of common cold symptoms by vitamin C
was not statistically significant according to Truswell (25)
Study (Ref.) No. ofsubjects
Vitamin C
dose (g/d)
Effect of
vitamin C (%)
P
(two-tailed) Outcome
Karlowski et al. 1975 (10, 11) 103 6 ?17 0.047 Duration of symptoms
Pitt & Costrini 1979 (12) 674 2 ?5 0.023 Severity of symptoms
Ludvigsson et al. 1977 (38)* 158 1 ?39 0.003 Duration of symptoms
Ludvigsson et al. 1977 (38)* 615 1 ?14 0.016 Absence from school
Carr et al. 1981 (39) 190 1 ?19 <0.05 Duration of symptoms
Wilson et al. 1973 (40)† 128 0.2 ?45 0.035 Intensity of symptoms
In all listed studies placebo was administered to the control subjects, and the effect refers to the
difference between the vitamin C and  placebo groups. The exact P values were calculated when
appropriate data were available.
* Ludvigsson reported the results of two separate studies in the same paper.
† "Whole colds" among girls administered 0.2 g/d of vitamin C; for details, see ref. 40.
DISCUSSION
Conceptual Problems in the Interpretation of Common Cold Studies
In 1971 Pauling carried out a meta-analysis of four placebo-controlled vitamin C-common
cold studies, calculating that there was very low probability (P < 0.00003; ref. 2) that all the
reported benefits were purely due to chance. There were technical deficiencies in the studies
on which Pauling based his hypothesis and consequently it was possible that the apparent
effects were due to biases in the studies. Nevertheless, trials carried out since the early 1970s
have consistently shown that vitamin C supplementation alleviates the symptoms of the
common cold, indicating that the vitamin does indeed have physiologic effects (Tables I and II;
ref. 3,4,41). With this experimental background it seems surprising that a widely held opinion
that vitamin C has no proven effects on the common cold persists (20-25).
Usually the evaluation of the potential effectiveness of a therapeutic method depends
greatly on the possibility of biologically rationalizing the method. Goodwin and Goodwin
(42,43) reviewed several cases in which an effective method of treatment was erroneously
rejected due to a lack of understanding of the physiologic mechanism of the effect. Thus,
the question in evaluating a new method of therapy is not just whether a moderate effect is
reproducible in controlled trials.
It seems quite clear that the great quantitative variation in the results is one of the factors
hampering the conclusion that vitamin C has real effects on the severity of colds. However, it
has been previously proposed that there also are conceptually much deeper problems in the
interpretation of the results, at the paradigm level, to use Thomas Kuhn’s terminology (44-46).
Traditionally it has been assumed that vitamin C only prevents scurvy and apparently this
notion has created strong prejudices against all other physiologic effects produced by this
vitamin (11,44,45).
The view that vitamin C has some effects on the immune system and on the
susceptibility to infections is an old one, long predating Pauling’s analyses (47-49). Also, it
7has been known since the 1940s that the concentration of vitamin C in leukocytes is tens of
times higher than in blood plasma (50,51), and it was known even earlier that leukocytes
participate in defense against infectious agents. It does not seem reasonable to assume that
leukocytes would serve only as a storage compartment, and the high concentration of
vitamin C thus suggests that it has functional roles in these immune system cells. Had the
reviewers been more familiar with the previous work on vitamin C and the immune system,
they might presumably have been more rigorous in their analyses of the common cold trials
(23-25).
The magnitude of the effect considered clinically significant may also be an issue
confounding the analysis of the common cold studies. Many antibiotics have truly
dramatic effects on certain bacterial infections and vitamin C has such an effect on scurvy.
Possibly the reviewers had such truly dramatic effects in mind when considering whether
vitamin C has clinically meaningful effects on colds. For example, Dykes and Meier (24)
said of Anderson’s 1972 study that “the estimated effect is considerably less than that
predicted by Pauling for the dose level.” Anderson had reported a 30% decrease (P <
0.001) in the total number of days confined to house per subject (5). Many people might
consider that with an inexpensive nutrient that costs pennies per gram and that is safe in
large doses (41,52,53) even such moderate benefits are worthy of exploitation irrespective
of how they compare to Pauling’s predictions.
A further conceptual problem may be the high doses of vitamin C used in the studies. The
doses that have consistently shown benefits (1–6 g/d) are some hundreds of times greater
than the doses which prevent scurvy (0.01 g/d; ref. 20,51). Consequently, the doses used in the
common cold studies may appear “pharmacologic” rather than “physiologic.” However, it has
been estimated that the diet of our ancestors contained 0.4–2.0 g/d of vitamin C (41,54,55),
and the gorilla, a close biological relative of ours, obtains some grams of vitamin C per day in
its diet (49). Evidently there has been an evolutionary trend in our ancestors to manage with
smaller vitamin C intakes, especially in the Northern regions where fruits were not available. No
strong conclusions can therefore be drawn from the evolutionary data as regards the optimum
dose for modern human beings. Nevertheless, the evolutionary data indicate that gram doses of
the vitamin are not strictly unfamiliar to human physiology.
Finally, one problem in the analysis of the vitamin C supplementation studies may be the
social implications. For example, if vitamin supplements are shown to be beneficial for certain
purposes, there may be a concern that some people would prefer to eat a poor quality diet and
supplement it with vitamins rather than eat a higher quality diet containing lots of fruits and
vegetables. It is also possible that any modest effects may be greatly exaggerated by commercial
entrepreneurs. Nevertheless, such social concerns should not bias investigation of the actual
scientific questions, although they should make a reviewer cautious in the exact formulation of
his or her conclusions.
Pauling complained that many of his critics had not read either his texts or the original reports
carefully, giving several examples to support his assertion (41). The diverse and numerous
shortcomings in the three major reviews discussed here support Pauling’s allegations. In fact,
motivated by the numerous shortcomings in the Dykes and Meier review, Pauling submitted
an analysis of the vitamin C-common cold studies to the Journal of the American Medical
Association. It was rejected even though Pauling twice made revisions to meet the suggestions
of the referees (30,41) and it was finally published elsewhere (29,30). As a further example of
careless reading or reporting by Pauling's critics, Chalmers claimed that “Pauling averaged P
values from the different studies” (23). However, in his statistical analysis Pauling (2)
explicitly used the well-established Fisher procedure of combining independent P values (17-
19), which cannot be described as naive averaging of the P values.
8Open Questions
Looking at the studies published to date, it seems clear that Pauling was too optimistic as
regards the quantitative benefits of vitamin C supplementation, although he was correct in his
general conclusion that the physiologic effects of vitamin C are not limited to the prevention
of scurvy. Pauling (1,2) suggested that large doses of the vitamin would substantially
decrease the incidence of colds. It is possible that vitamin C supplementation decreases the
common cold incidence in certain restricted groups of people (56,57), but there seems to be
no worthwhile effect on cold incidence in the general population of Western countries
(3,4,56). Pauling's other conclusion, that vitamin C ameliorates the symptoms of the common
cold, has been corroborated in subsequent work, but the benefit has been smaller than he
thought (1-4).
Although placebo-controlled trials have shown that vitamin C has physiologic effects on
the common cold, there are scores of open questions awaiting answers. For example, in the
case of treating the common cold, it may be asked what is the best method of
supplementation, what are the optimum doses, what is the maximum treatment effect, and
how does the benefit vary among different groups of people? It also seems important to
understand the biochemical mechanisms of the effect as this could eventually help in the
identification of groups of people who would benefit most. Furthermore, it may be asked
whether vitamin C supplementation has moderate effects on certain other diseases, as has
been suggested in a few recent reviews (41,53,58-63).
Such questions are important, yet they are not often asked. For example, they have been
disregarded in the recommended dietary allowances monograph on nutritional
recommendations (20), which is concerned only with the prevention of overt scurvy
(41,44,45,62-69). It is noteworthy and quite surprising that in this influential monograph,
Chalmers’ review (23) and Dykes and Meier’s review (24) are used as the basis for claiming
that vitamin C has no proven effects on the common cold (20), although some of the notable
shortcomings of both reviews should have been apparent to anyone familiar with the original
publications.
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